KLK3 Protein

Kallikrein-3 Recombinant Human

Recombinant Human Kallikrein-3, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 237 amino acids. With a molecular weight of 26.1 kDa, KLK3 is purified using proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT4209
Source

Escherichia Coli.

Appearance

Sterile Filtered White lyophilized (freeze-dried) powder.

KLK13 Human

Kallikrein-13 Human Recombinant

Recombinant human KLK13, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 284 amino acids (residues 17-277). It has a molecular weight of 31.3 kDa. The KLK13 protein is fused to a 23 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT3579
Source
Escherichia Coli.
Appearance
A sterile, colorless solution that has been filtered.

KLK3, His

Kallikrein-3 Human Recombinant, His Tag

Recombinant human KLK3, expressed in E. coli, is a single, non-glycosylated polypeptide chain. This protein consists of 262 amino acids (residues 25-261) with a molecular weight of 28.8 kDa. The KLK3 protein is purified using proprietary chromatographic techniques and includes a 25 amino acid His-Tag fused at the N-terminus.
Shipped with Ice Packs
Cat. No.
BT4305
Source
Escherichia Coli.
Appearance
Clear, sterile filtered solution.

KLK5 Human

Kallikrein-5 Human Recombinant

Recombinant human KLK5, produced in E.coli, is a single, non-glycosylated polypeptide chain comprising 252 amino acids (67-293) with a molecular weight of 27.8kDa. A 25 amino acid His-tag is fused to the N-terminus of KLK5, which is then purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT4391
Source
Escherichia Coli.
Appearance
Clear, sterile filtered solution.

KLK5 Human, Sf9

Kallikrein-5 Human Recombinant, Sf9

Recombinant human Kallikrein-5, produced in Sf9 Baculovirus cells, is a single, glycosylated polypeptide chain of 236 amino acids (67-293 a.a.). It has a molecular mass of 26.2 kDa and appears at 28-40 kDa on SDS-PAGE under reducing conditions. This KLK5 protein is expressed with a C-terminal 6-amino acid His tag and purified using proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT4477
Source
Sf9, Baculovirus cells.
Appearance
A sterile, colorless solution.

KLK7 Human

Kallikrein-7 Human Recombinant

This product consists of a recombinant human KLK7 protein produced in E.coli. It is engineered as a single polypeptide chain without any glycosylation modifications. The protein sequence includes amino acids 30 to 253 of the native KLK7 sequence, resulting in a molecular weight of 27.1 kDa. For purification and detection purposes, a 25 amino acid His-Tag is attached to the N-terminus of the protein. The purification process utilizes proprietary chromatographic techniques to ensure high purity.
Shipped with Ice Packs
Cat. No.
BT4520
Source
Escherichia Coli.
Appearance
A clear solution that has been sterilized through filtration.

KLK7 Human, sf9

Kallikrein-7 Human Recombinant, sf9

KLK7, expressed in Sf9 insect cells using a baculovirus expression system, is a single, glycosylated polypeptide chain. It consists of 190 amino acids, with amino acids 1 to 181 representing the mature KLK7 sequence. The molecular mass of KLK7 is 20.9 kDa. On SDS-PAGE under reducing conditions, it migrates with an apparent molecular weight of 28-40 kDa due to glycosylation. KLK7 is engineered with a 6-amino acid His tag at the C-terminus to facilitate purification. The protein is purified using proprietary chromatographic techniques to ensure high purity.
Shipped with Ice Packs
Cat. No.
BT4587
Source
Sf9, Baculovirus cells.
Appearance
Clear, colorless solution, sterile-filtered.

KLK13 Human, sf9

Kallikrein-13 Human Recombinant, sf9

KLK13, produced using Sf9 Baculovirus cells, is a single, glycosylated polypeptide chain comprised of 267 amino acids (spanning positions 17 to 277). It possesses a molecular mass of 29.7 kDa. On SDS-PAGE, its molecular size appears within the range of approximately 28-40 kDa. KLK13 is expressed with a 6-amino acid His tag located at its C-terminus and is subsequently purified through proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT3651
Source
Sf9, Baculovirus cells.
Appearance
The product is a sterile-filtered solution, colorless in appearance.

KLK15 Human

Kallikrein-15 Human Recombinant

Recombinant human KLK15, expressed in E. coli, is a non-glycosylated polypeptide chain with a molecular weight of 28.2 kDa. The protein consists of 258 amino acids (22-256a.a) and includes a 23 amino acid His-tag at the N-terminus. Purification is achieved through proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT3718
Source
Escherichia Coli.
Appearance
A clear, colorless solution that has been sterilized by filtration.

KLK15 Human, sf9

Kallikrein-15 Human Recombinant, sf9

Recombinantly produced in Sf9 Baculovirus cells, KLK15 Human Recombinant is a single, glycosylated polypeptide chain consisting of 249 amino acids (17-256a.a.). With a molecular mass of 27.4kDa, it appears on SDS-PAGE around 28-40kDa. The protein features a 6 amino acids His tag at the C-terminus and undergoes purification through proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT3787
Source
Sf9, Baculovirus cells.
Appearance
The product is a sterile-filtered solution, colorless in appearance.
Definition and Classification

Kallikreins are a subgroup of serine proteases, enzymes capable of cleaving peptide bonds in proteins. In humans, they are classified into two main types: plasma kallikrein and tissue kallikreins. Plasma kallikrein is encoded by the KLKB1 gene and has no known paralogue, while tissue kallikrein-related peptidases (KLKs) encode a family of fifteen closely related serine proteases . These genes are localized to chromosome 19q13, forming the largest contiguous cluster of proteases within the human genome .

Biological Properties

Key Biological Properties: Kallikreins are involved in various physiological functions, including blood pressure regulation, semen liquefaction, and skin desquamation .

Expression Patterns and Tissue Distribution: Kallikreins are expressed in many tissues, including the prostate, breast, ovary, and testis . They are also found in biological fluids such as seminal plasma, breast milk, and cerebrospinal fluid . Some kallikreins have restricted expression patterns, while others are widely distributed across different tissues .

Biological Functions

Primary Biological Functions: Kallikreins play a crucial role in regulating blood pressure, semen liquefaction, and skin desquamation . They are also involved in the activation of inflammation and the regulation of electrolyte balance .

Role in Immune Responses and Pathogen Recognition: Kallikreins are implicated in immune responses by activating kinins, which are peptides responsible for inflammation and vasodilation . They also play a role in pathogen recognition by modulating the activity of immune cells .

Modes of Action

Mechanisms with Other Molecules and Cells: Kallikreins interact with various molecules and cells through proteolytic cascades. For example, plasma kallikrein liberates kinins from kininogens, which regulate blood pressure and inflammation .

Binding Partners and Downstream Signaling Cascades: Kallikreins bind to kininogens to release kinins, which then activate B1 and B2 receptors, leading to downstream signaling cascades that regulate blood pressure, inflammation, and other physiological processes .

Regulatory Mechanisms

Regulatory Mechanisms Controlling Expression and Activity: Kallikrein expression is regulated by steroid hormones such as androgens, estrogens, and glucocorticoids . Their activity is controlled through zymogen activation, endogenous inhibitors like serpins, and internal (auto)cleavage leading to inactivation .

Transcriptional Regulation and Post-Translational Modifications: Kallikreins undergo transcriptional regulation by steroid hormones and post-translational modifications such as glycosylation, which affect their stability and activity .

Applications

Biomedical Research: Kallikreins are studied for their role in various physiological and pathological processes, including cancer, cardiovascular diseases, and neurodegenerative disorders .

Diagnostic Tools: Prostate-specific antigen (PSA; KLK3) and human glandular kallikrein (hK2) are used as tumor markers for prostate cancer . Other kallikreins are emerging as biomarkers for ovarian and breast cancers .

Therapeutic Strategies: Kallikrein inhibitors are being developed for the treatment of hereditary angioedema and other inflammatory conditions . Recombinant tissue kallikrein is also being explored for therapeutic use in ischemic stroke and renal disease .

Role in the Life Cycle

Role Throughout the Life Cycle: Kallikreins play a role in various stages of life, from development to aging and disease. They are involved in skin desquamation, seminal clot liquefaction, and neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases . Dysregulated kallikrein expression is associated with cancer progression and other age-related diseases .

© Copyright 2025 TheBiotek. All Rights Reserved.